Literature DB >> 2106431

A nonoxytocinergic prolactin releasing factor and a nondopaminergic prolactin inhibiting factor in bovine neurointermediate lobe extracts: in vitro and in vivo studies.

W K Samson1, L Martin, R J Mogg, R J Fulton.   

Abstract

Several peptidergic PRL-releasing factors (PRFs) have been described; however, none have been proven to be of primary physiological importance in the control of hormone release. Similarly dopamine withdrawal alone cannot completely explain the profiles of PRL secretion observed under a variety of conditions. We describe here the isolation in semipurified form of both a PRF and a PRL-inhibiting factor (PIF) from bovine neurointermediate lobe (NIL) extracts. Acid extracts of bovine NILs stimulated, in a dose-related manner, PRL release from cultured anterior pituitary cells, even after immunoabsorption of endogenous oxytocin from the extract. PIF and PRF activities were semipurified from NIL extracts by Sephadex chromatography and detected by in vitro and in vitro bioassays. The PRF material could be separated from oxytocin by gel sieving and was active in the presence of dopamine in vitro unlike synthetic oxytocin and in cell preparations in which the oxytocin-responsive lactotrophs had been removed by selective cytotoxin cell targeting using an oxytocin-ricin A chain cytotoxic conjugate. The PRF material stimulated PRL secretion in a dose-dependent fashion in conscious male rats after iv injection. The PIF material comigrated on sizing gel chromatography with immunoreactive oxytocin and was active in vitro during dopamine blockade with domperidone and in vivo in the presence of endogenous dopaminergic tone. These data suggest that novel factors present in the NIL might exert physiologically relevant control over lactotroph function and add to the growing literature on the presence of a PRF in the NIL.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106431     DOI: 10.1210/endo-126-3-1610

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Prolactin regulation by heparin-binding growth factors expressed in mouse pituitary cell lines.

Authors:  Robert Hnasko; Nira Ben-Jonathan
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

2.  Prolactin-releasing peptide and its homolog RFRP-1 act in hypothalamus but not in anterior pituitary gland to stimulate stress hormone secretion.

Authors:  Willis K Samson; Cynthia Keown; Charles K Samson; Henry W Samson; Brian Lane; Jennifer R Baker; Meghan M Taylor
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

3.  Analyses for susceptibility of rat anterior pituitary cells to prolactin-releasing peptide.

Authors:  Y Kawamata; R Fujii; S Fukusumi; Y Habata; M Hosoya; S Hinuma; C Kitada; H Onda; O Nishimura; M Fujino
Journal:  Endocrine       Date:  2000-06       Impact factor: 3.633

4.  Central oxytocin inhibition of salt appetite in rats: evidence for differential sensing of plasma sodium and osmolality.

Authors:  R E Blackburn; W K Samson; R J Fulton; E M Stricker; J G Verbalis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

5.  A novel reproductive peptide, phoenixin.

Authors:  G L C Yosten; R-M Lyu; A J W Hsueh; O Avsian-Kretchmer; J-K Chang; C W Tullock; S L Dun; N Dun; W K Samson
Journal:  J Neuroendocrinol       Date:  2013-02       Impact factor: 3.627

Review 6.  60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-prolactin axis.

Authors:  David R Grattan
Journal:  J Endocrinol       Date:  2015-06-22       Impact factor: 4.286

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.